Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 21, 2021

View Archived Issues

Structure-based multivalent nanobodies neutralize SARS-CoV-2 and prevent viral escape

FDA clears IND for phase I trial of MT-6402 in PD-L1-positive solid tumors

FDA accepts C4 Therapeutics' IND for phase I/II trial of CFT-7455 in multiple myeloma and NHL

Gritstone develops second-generation vaccine against SARS-CoV-2

First patient dosed in phase I study of FT-7051 in metastatic CRPC

European Commission approves extension of the indication for Doptelet as treatment of ITP

Preliminary topline phase II data for NSI-566 in ischemic stroke

Positive confirmatory data from atopic dermatitis cohort of EDP-1815 phase Ib trial

Adamis submits IND to the FDA for tempol as treatment of COVID-19

National University of Singapore, Nanyang Technological University patent RNA editing inhibitors

New cannabinoid CB1/CB2 receptor ligands presented by Canopy Growth Corp.

Merck & Co. discovers antituberculosis compounds

Long-term phase III data for lisdexamfetamine dimesylate in preschool-aged children with ADHD

Big picture look reveals RNA-binding proteins' role in psychiatric disorders

Arcutis plans to study roflumilast foam in phase III for seborrheic dermatitis

12-Week study shows benvitimod cream is efficacious and safe in plaque psoriasis

FDA approves IND for phase IIa study of JNJ-40411813 in epilepsy

Inhibitor BAS-2 illuminates role of HDAC6 in glycolytic metabolism in TNBC

c2H2/c3C1, a two-MAb cocktail with high therapeutic efficacy against SARS-CoV-2 infections

Tavotek Biotherapeutics presents bispecific antibodies to TNF-alpha, IL-1beta

Interim phase I data on OTX-TIC in primary open-angle glaucoma or ocular hypertension

MCB-613 attenuates loss of cardiac function after myocardial infarction

Thetis completes pre-IND meeting for TP-317 for inflammatory bowel disease

PK and PD data presented for ADAIR, an IR formulation of dextroamphetamine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...